Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Active, Not Recruiting

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

NCT04439344

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

NCT04439123

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

NCT03560882

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Cancer, +13 more
Locations: University of Kansas Cancer Center - CRC Fairway, Kansas, United States

View Trial Details

Active, Not Recruiting

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

NCT04439175

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer

NCT05055011

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device

NCT02600208

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Active, Not Recruiting

A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

NCT05347225

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: Guangdong Provincial People's Hospital-hematology department ( Site 1002) Guangzhou, Guangdong, China

SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal medicine ( Site 1007) Guangzhou, Guangdong, China

Henan Cancer Hospital-hematology department ( Site 1003) Zhengzhou, Henan, China

Hunan Cancer Hospital ( Site 1004) Changsha, Hunan, China

View Trial Details

Active, Not Recruiting

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

NCT02993146

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +11 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

NCT04439136

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)

NCT04439253

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Hematologic Neoplasms

Hematologic Neoplasms trial results

Related conditions